Evidence map›Paper›PMID 18241231›Full record

ArticleClinical and experimental immunology2008

Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy.

L Landrø, J K Damås, T H Flo, L Heggelund, T Ueland, G E Tjønnfjord, T Espevik, P Aukrust, S S Frøland

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Serum siderocalin levels in patients with tuberculosis and HIV infection.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  4. Article
  5. Article
  6. Siderophore-based immunization strategy to inhibit growth of enteric pathogens.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

L LandrøResearch Institute for Internal Medicine, Rikshospitalet-Radiumhospitalet Medical Center, Unviersity of Oslo, Oslo, Norway. linn.landro@medisin.uio.no
J K Damås
T H Flo
L Heggelund
T Ueland
G E Tjønnfjord
T Espevik
P Aukrust
S S Frøland
Office of Infectious Diseases · USNorwegian University of Science and Technology · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although neutrophil gelatinase-associated lipocalin (NGAL) may play a pivotal role in the innate immune response, there are currently no data on NGAL levels in human immunodeficiency virus (HIV)-infected patients. In this study we aimed to examine the regulation of NGAL in HIV infection. The regulation of NGAL in HIV infection was examined by different experimental approaches, including studies in peripheral blood and mononuclear cells (MNC) from bone marrow aspirates before and during highly active anti-retroviral therapy (HAART). We found that: before initiating HAART, HIV-infected patients (n = 37) had significantly decreased serum NGAL levels compared with healthy controls (n = 26); (ii) during HAART, there was a gradual and significant increase in NGAL concentrations reaching levels comparable to those in healthy controls after 12 months; (iii) this increase was seen primarily in virological responders to HAART (HIV RNA level <200 copies/ml after 24 months); (iv) phytohaemagglutinin-stimulated NGAL release in MNC cells from bone marrow aspirates was decreased in untreated HIV-infected patients compared with healthy controls, but increased after 26 weeks on HAART; and (v) there was a significant positive correlation between neutrophil counts and NGAL levels at all time-points during HAART. We have shown decreased NGAL levels in HIV-infected patients, potentially reflecting decreased number and function of neutrophils as well as impaired bone marrow myelopoiesis. These abnormalities were reversed by successful HAART. Our findings underscore further the involvement of neutrophils and innate immunity in HIV-related immunodeficiency.

Indexed as

Acute-Phase ProteinsAdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBone Marrow CellsCD4 Lymphocyte CountCells, CulturedFemaleHIV-1HIV InfectionsHumansLipocalin-2LipocalinsMaleMiddle AgedNeutrophilsAcute-Phase ProteinsAnti-HIV AgentsLCN2 protein, humanLipocalin-2LipocalinsProto-Oncogene ProteinsRNA, Viral

Identifiers

PMID18241231
PMCPMC2384072
OpenAlexW1558925600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.